Clindamycin HCl Capsule recalled over manufacturing violations
- Recall date
- April 22, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- RemedyRePack Inc. recalls Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15…
- Recall number
- D-0411-2025
- FDA classification
- Class II
- Brand / firm
- RemedyRePack Inc.
- Sold / distributed
- Within U.S - PA, VA, FL.
Why it was recalled
CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02
Get recall alerts
Free email alert whenever RemedyRePack Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: RemedyRePack Inc.